Health Condition 1: O280- Abnormal hematological finding onantenatal screening of mother
Conditions
Interventions
None listed
Sponsors
Principal
Solent Healthcare A Div of Maksun Biotech
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients primarily diagnosed on the basis of signs and symptoms of the pregnancy anemia and later confirmed by laboratory investigation of anemia i.e. Hb gm%, S. Ferritin, PBF etc. will be selected. 2. Women having pregnancy between 12th week to 32nd week will be registered. 3. Pregnant women having hemoglobin level between 8- 11 gm% to be included in the trial. 4. Patients of age group 20- 35 years.
Exclusion criteria
Exclusion criteria: 1. Pregnant women having hemoglobin level below 8 gm%. 2. Age of patient more than 35 years or less than 20 years. 3. All pregnant anemic patients having complications like, Cardivascular disorders, Hemolytic disorders, Thyroid dysfunction, Achlorhydria, Irritable Bowel Syndrome, Renal Diseases, Gestational Diabetes and with any other systemic or metabolic disorders. 4. Anemia due to hemorrhagic causes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of millet powder (Bajra- Ragi) a Pathya Kalpana as adjuvant with standard Ferrous Sulphate tablet in Garbhini Pandu i.e. Iron deficiency anemia in pregnancy.Timepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To establish the use of millets for its health benefits during pregnancy as standard fare.Timepoint: 45 days | — |
Countries
India
Contacts
Public ContactDr Swati Sharma
Himachal Pradesh University
Outcome results
None listed